Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,400 peer-reviewed publications.

The CPRD bibliography is updated on a monthly basis (last updated 6 January 2020) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download: 

(PDF, 3MB, 195 pages)

 

Export 2411 results:
Author Title Type [ Year(Asc)]
2019
L. Fiaschi, Nelson-Piercy, C., Deb, S., King, R., and Tata, L. J., “Clinical management of nausea and vomiting in pregnancy and hyperemesis gravidarum across primary and secondary care: a population based study”, Bjog, 2019.
F. Nissen, Douglas, I. J., Mullerova, H., Pearce, N., Bloom, C. I., Smeeth, L., and Quint, J. K., “Clinical profile of predefined asthma phenotypes in a large cohort of UK primary care patients (Clinical Practice Research Datalink)”, J Asthma Allergy, vol. 12, pp. 7-19, 2019.
D. Metcalfe, Masters, J., Delmestri, A., Judge, A., Perry, D., Zogg, C., Gabbe, B., and Costa, M., “Coding algorithms for defining Charlson and Elixhauser co-morbidities in Read-coded databases”, BMC Med Res Methodol, vol. 19, p. 115, 2019.
A. Dregan, Matcham, F., Harber-Aschan, L., Rayner, L., Brailean, A., Davis, K., Hatch, S., Pariante, C., Armstrong, D., Stewart, R., and Hotopf, M., “Common mental disorders within chronic inflammatory disorders: a primary care database prospective investigation”, Ann Rheum Dis, 2019.
A. Schultze, Graham, S., Nordstrom, B. L., Mehmud, F., and Ramagopalan, S. V., “Commonly used definitions in real-world studies may underestimate the prevalence of renal disease among nonvalvular atrial fibrillation patients”, J Comp Eff Res, 2019.
M. Nowakowska, Zghebi, S. S., Ashcroft, D. M., Buchan, I., Chew-Graham, C., Holt, T., Mallen, C., van Marwijk, H., Peek, N., Perera-Salazar, R., Reeves, D., Rutter, M. K., Weng, S. F., Qureshi, N., Mamas, M. A., and Kontopantelis, E., “The comorbidity burden of type 2 diabetes mellitus: patterns, clusters and predictions from a large English primary care cohort”, BMC Med, vol. 17, p. 145, 2019.
I. J. Chou, Kuo, C. F., Tanasescu, R., Tench, C. R., Tiley, C. G., Constantinescu, C. S., and Whitehouse, W. P., “Comorbidity in multiple sclerosis: its temporal relationships with disease onset and dose effect on mortality”, Eur J Neurol, 2019.
A. Douros, Dell'Aniello, S., Yu, O. H. Y., and Suissa, S., “Comparative cardiovascular and hypoglycemic safety of glimepiride in type 2 diabetes: A population-based cohort study”, Diabetes Obes Metab, 2019.
S. Suissa, Dell'Aniello, S., and Ernst, P., “Comparative effectiveness and safety of LABA-LAMA versus LABA-ICS treatment of COPD in real world clinical practice”, Chest, 2019.
S. J. Sinnott, Smeeth, L., Williamson, E., Perel, P., Nitsch, D., Tomlinson, L. A., and Douglas, I. J., “The comparative effectiveness of fourth-line drugs in resistant hypertension: An application in electronic health record data”, Pharmacoepidemiol Drug Saf, 2019.
S. Suissa, Dell'Aniello, S., and Ernst, P., “Comparative effects of LAMA-LABA-ICS versus LAMA-LABA for COPD: Cohort study in real world clinical practice: LAMA-LABA-ICS versus LAMA-LABA in COPD”, Chest, 2019.
D. B. Price, Carter, V., Martin, J., Gardener, E. A., Skinner, D., Yang, S., Hoffman, M., Willis, J. C., and Cooper, A. J., “Comparative Safety Profile of the Fixed-Dose Combination Corticosteroid and Long-acting beta2-Agonist Fluticasone Propionate/Formoterol Fumarate: A 36-Month Longitudinal Cohort Study in UK Primary Care”, Drugs, 2019.
K. Mansfield, Crellin, E., Denholm, R., Quint, J. K., Smeeth, L., Cook, S., and Herrett, E., “Completeness and validity of alcohol recording in general practice within the UK: a cross-sectional study”, BMJ Open, vol. 9, p. e031537, 2019.
M. Pufulete, Harris, J., Sterne, J. A. C., Johnson, T. W., Lasserson, D., Mumford, A., Doble, B., Wordsworth, S., Benedetto, U., Rogers, C. A., Loke, Y., Pithara, C., Redwood, S., and Reeves, B. C., “Comprehensive ascertainment of bleeding in patients prescribed different combinations of dual antiplatelet therapy (DAPT) and triple therapy (TT) in the UK: study protocol for three population-based cohort studies emulating 'target trials' (the ADAPTT Stu”, BMJ Open, vol. 9, p. e029388, 2019.
M. E. Saine, Carbonari, D. M., Newcomb, C. W., Gallagher, A. M., Blak, B. T., Roy, J. A., Wood, J., Cardillo, S., Hennessy, S., Strom, B. L., and , “Concordance of hospitalizations between Clinical Practice Research Datalink and linked Hospital Episode Statistics among patients treated with oral antidiabetic therapies”, Pharmacoepidemiol Drug Saf, 2019.
C. I. Bloom, Douglas, I., Olney, J., D'Ancona, G., Smeeth, L., and Quint, J. K., “Cost saving of switching to equivalent inhalers and its effect on health outcomes”, Thorax, 2019.
S. V. Ramagopalan, Samnaliev, M., Weir, S., Sammon, C. J., Carroll, R., and Alikhan, R., “Costs of gastrointestinal bleeding events in atrial fibrillation: a UK Clinical Practice Research Datalink study”, Future Cardiol, 2019.
O. A. Oshagbemi, Franssen, F. M. E., Wouters, E. F. M., van der Zee, A. H. Maitlan, Driessen, J. H. M., de Boer, A., and de Vries, F., “C-reactive protein as a biomarker of response to inhaled corticosteroids among patients with COPD”, Pulm Pharmacol Ther, p. 101870, 2019.
M. Touya, Lamy, F. X., Tanasescu, A., Saragoussi, D., Francois, C., Wade, A. G., Llorca, P. M., Lancon, C., and Falissard, B., “Creation and validation of a linear index to measure the health state of patients with depression in automated healthcare databases”, J Mark Access Health Policy, vol. 7, p. 1674115, 2019.
A. Wolf, Dedman, D., Campbell, J., Booth, H., Lunn, D., Chapman, J., and Myles, P., “Data resource profile: Clinical Practice Research Datalink (CPRD) Aurum”, Int J Epidemiol, 2019.
A. Douros, Dell'Aniello, S., Dehghan, G., Boivin, J. F., and Renoux, C., “Degree of serotonin reuptake inhibition of antidepressants and ischemic risk: A cohort study”, Neurology, vol. 93, pp. e1010-e1020, 2019.
C. S. Arhi, Markar, S., Burns, E. M., Bouras, G., Bottle, A., Hanna, G., Aylin, P., Ziprin, P., and Darzi, A., “Delays in referral from primary care are associated with a worse survival in patients with esophagogastric cancer”, Dis Esophagus, 2019.
S. Hawley, Edwards, C. J., Arden, N. K., Delmestri, A., Cooper, C., Judge, A., and Prieto-Alhambra, D., “Descriptive epidemiology of hip and knee replacement in rheumatoid arthritis: an analysis of UK electronic medical records”, Semin Arthritis Rheum, 2019.
H. Bricout, Torcel-Pagnon, L., Lecomte, C., Almas, M. F., Matthews, I., Lu, X., Wheelock, A., and Sevdalis, N., “Determinants of shingles vaccine acceptance in the United Kingdom”, PLoS One, vol. 14, p. e0220230, 2019.
S. Harmala, O'Brien, A., Parisinos, C. A., Direk, K., Shallcross, L., and Hayward, A., “Development and validation of a prediction model to estimate the risk of liver cirrhosis in primary care patients with abnormal liver blood test results: protocol for an electronic health record study in Clinical Practice Research Datalink”, Diagn Progn Res, vol. 3, p. 10, 2019.
R. Alsaggaf, Pfeiffer, R. M., Wang, Y., St George, D. M. M., Zhan, M., Wagner, K. R., Amr, S., Greene, M. H., and Gadalla, S. M., “Diabetes, Metformin, and Cancer Risk in Myotonic Dystrophy Type I”, Int J Cancer, 2019.
N. Conrad, Judge, A., Canoy, D., Tran, J., O'Donnell, J., Nazarzadeh, M., Salimi-Khorshidi, G., Hobbs, F. D. R., Cleland, J. G., McMurray, J. J. V., and Rahimi, K., “Diagnostic tests, drug prescriptions, and follow-up patterns after incident heart failure: A cohort study of 93,000 UK patients”, PLoS Med, vol. 16, p. e1002805, 2019.
D. Stolz, Kostikas, K., Loefroth, E., Fogel, R., Gutzwiller, F. S., Conti, V., Cao, H., and Clemens, A., “Differences in COPD exacerbation risk between women and men: analysis from the UK Clinical Practice Research Datalink data”, Chest, 2019.
A. Douros, Rouette, J., Yin, H., Yu, O. H. Y., Filion, K. B., and Azoulay, L., “Dipeptidyl Peptidase-4 Inhibitors and the Risk of Bullous Pemphigoid Among Patients With Type 2 Diabetes”, Diabetes Care, 2019.
S. V. Ramagopalan, Graham, S., Carroll, R., Raluy-Callado, M., Nordstrom, B. L., Donaldson, R., Colby, C., Mehmud, F., and Alikhan, R., “Discontinuation and primary care visits in nonvalvular atrial fibrillation patients treated with apixaban or warfarin”, J Comp Eff Res, 2019.
G. Nakafero, Grainge, M., Valdes, A., Townsend, N., Mallen, C., Zhang, W., Doherty, M., Mamas, M. A., and Abhishek, A., “Do beta-adrenoreceptor blocking drugs associate with reduced risk of symptomatic osteoarthritis and total joint replacement in the general population? A primary care-based, prospective cohort study using the Clinical Practice Research Datalink”, BMJ Open, vol. 9, p. e032050, 2019.
Y. Li, Sperrin, M., Belmonte, M., Pate, A., Ashcroft, D. M., and van Staa, T. P., “Do population-level risk prediction models that use routinely collected health data reliably predict individual risks?”, Sci Rep, vol. 9, p. 11222, 2019.
I. Karp, Sivaswamy, A., and Booth, C., “Does the use of incretin-based medications increase the risk of cancer in patients with type-2 diabetes mellitus?”, Pharmacoepidemiol Drug Saf, 2019.
Y. Tao and Fu, H., “Doubly robust estimation of the weighted average treatment effect for a target population”, Stat Med, vol. 38, pp. 315-325, 2019.
A. Jaggi, Nazir, J., Fatoye, F., Siddiqui, E., Choudhury, N., Argoubi, R., Ali, M., de Ridder, D., and Drake, M. J., “Drug utilization patterns and healthcare resource use and costs in patients with neurogenic bladder in the United Kingdom: A retrospective primary care database study”, Neurourol Urodyn, 2019.
R. Y. L. Kuo, Ng, M., Prieto-Alhambra, D., and Furniss, D., “Dupuytren's disease predicts increased all-cause and cancer-specific mortality: analysis of a large cohort from the UK Clinical Practice Research Datalink”, Plast Reconstr Surg, 2019.
M. L. Henry, Abdul-Sultan, A., Walker, A. J., West, J., and Humes, D. J., “Duration and Magnitude of Postoperative Risk of Venous Thromboembolism after Cholecystectomy: A Population-Based Cohort Study”, Dig Surg, pp. 1-7, 2019.
O. M. Moussa, Ardissino, M., Kulatilake, P., Faraj, A., Muttoni, E., Darzi, A., Ziprin, P., Scholtz, S., and Purkayastha, S., “Effect of body mass index on depression in a UK cohort of 363 037 obese patients: A longitudinal analysis of transition”, Clin Obes, p. e12305, 2019.
G. S. Matharu, Mouchti, S., Twigg, S., Delmestri, A., Murray, D. W., Judge, A., and Pandit, H. G., “The effect of smoking on outcomes following primary total hip and knee arthroplasty: a population-based cohort study of 117,024 patients”, Acta Orthop, pp. 1-9, 2019.
M. J. Cook, Sorial, A. K., Lunt, M., Board, T. N., and O'Neill, T. W., “Effect of timing and duration of statin exposure on risk of hip or knee revision arthroplasty: a population-based cohort study”, J Rheumatol, 2019.
M. C. Gulliford, Prevost, A. T., Charlton, J., Juszczyk, D., Soames, J., McDermott, L., Sultana, K., Wright, M., Fox, R., Hay, A. D., Little, P., Moore, M. V., Yardley, L., and Ashworth, M., “Effectiveness and safety of electronically delivered prescribing feedback and decision support on antibiotic use for respiratory illness in primary care: REDUCE cluster randomised trial”, Bmj, vol. 364, p. l236, 2019.
K. Marinier, Macouillard, P., de Champvallins, M., Deltour, N., Poulter, N., and Mancia, G., “Effectiveness of two-drug therapy versus monotherapy as initial regimen in hypertension: A propensity score-matched cohort study in the UK Clinical Practice Research Datalink”, Pharmacoepidemiol Drug Saf, 2019.
K. Mattishent, Richardson, K., Dhatariya, K., Savva, G. M., Fox, C., and Loke, Y. K., “The effects of hypoglycemia and dementia on cardiovascular events, falls and fractures and all-cause mortality in older people - a retrospective cohort study”, Diabetes Obes Metab, 2019.
M. C. Gulliford, Juszczyk, D., Prevost, A. T., Soames, J., McDermott, L., Sultana, K., Wright, M., Fox, R., Hay, A. D., Little, P., Moore, M., Yardley, L., Ashworth, M., and Charlton, J., “Electronically delivered interventions to reduce antibiotic prescribing for respiratory infections in primary care: cluster RCT using electronic health records and cohort study”, Health Technol Assess, vol. 23, pp. 1-70, 2019.
E. Herrett, Gadd, S., Jackson, R., Bhaskaran, K., Williamson, E., Van Staa, T., Sofat, R., Timmis, A., and Smeeth, L., “Eligibility and subsequent burden of cardiovascular disease of four strategies for blood pressure-lowering treatment: a retrospective cohort study”, Lancet, 2019.
H. Whittaker, Connell, O., Campbell, J., Elbehairy, A. F., Hopkinson, N. S., and Quint, J. K., “Eligibility for Lung Volume Reduction Surgery in Chronic Obstructive Pulmonary Disease patients identified in a UK primary care setting”, Chest, 2019.
R. Ferguson, Culliford, D., Prieto-Alhambra, D., Pinedo-Villanueva, R., Delmestri, A., Arden, N., and Bowen, C., “Encounters for foot and ankle pain in UK primary care: a population-based cohort study of CPRD data”, Br J Gen Pract, vol. 69, pp. e422-e429, 2019.
L. Horne, Ashfaq, A., MacLachlan, S., Sinsakul, M., Qin, L., LoCasale, R., and Wetmore, J. B., “Epidemiology and health outcomes associated with hyperkalemia in a primary care setting in England”, BMC Nephrol, vol. 20, p. 85, 2019.
S. Wood, Marchant, A., Allsopp, M., Wilkinson, K., Bethel, J., Jones, H., and John, A., “Epidemiology of eating disorders in primary care in children and young people: a Clinical Practice Research Datalink study in England”, BMJ Open, vol. 9, p. e026691, 2019.
I. J. Chou, Kuo, C. F., Tanasescu, R., Tench, C. R., Tiley, C. G., Constantinescu, C. S., and Whitehouse, W. P., “Epilepsy and associated mortality in patients with multiple sclerosis”, Eur J Neurol, vol. 26, pp. 342-e23, 2019.
[Page last reviewed 6 January 2020]